Modern Therapeutic Approaches for Noninfectious Ocular Diseases Involving Inflammation

被引:19
|
作者
Ratay, Michelle L. [1 ]
Bellotti, Elena [2 ]
Gottardi, Riccardo [3 ]
Little, Steven R. [4 ]
机构
[1] Univ Pittsburgh, Dept Bioengn, 427 Benedum Hall 3700 OHara St, Pittsburgh, PA 15261 USA
[2] Univ Pittsburgh, Dept Chem Engn, 427 Benedum Hall 3700 OHara St, Pittsburgh, PA 15261 USA
[3] Ri MED Fdn, Dept Orthoped Surg, Dept Chem Engn, 427 Benedum Hall 3700 OHara St, Pittsburgh, PA 15261 USA
[4] McGowan Inst Regenerat Med, Dept Pharmaceut Sci, Dept Immunol, Dept Chem Engn,Dept Bioengn,Dept Ophthalmol, 940 Benedum Hall 3700 OHara St, Pittsburgh, PA 15261 USA
基金
美国国家卫生研究院;
关键词
age-related macular degeneration; drug delivery; dry eye disease; therapeutics; uveitis; DRY EYE DISEASE; DRUG-DELIVERY SYSTEMS; REGULATORY T-CELLS; MEIBOMIAN GLAND DYSFUNCTION; LOW-DOSE CYCLOSPORINE; EMBRYONIC STEM-CELLS; LONG-TERM EFFICACY; MACULAR DEGENERATION; MYCOPHENOLATE-MOFETIL; FLUOCINOLONE ACETONIDE;
D O I
10.1002/adhm.201700733
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Dry eye disease, age-related macular degeneration, and uveitis are ocular diseases that significantly affect the quality of life of millions of people each year. In these diseases, the action of chemokines, proinflammatory cytokines, and immune cells drives a local inflammatory response that results in ocular tissue damage. Multiple therapeutic strategies are developed to either address the symptoms or abate the underlying cause of these diseases. Herein, the challenges to deliver drugs to the relevant location in the eye for each of these diseases are reviewed along with current and innovative therapeutic approaches that attempt to restore homeostasis within the ocular microenvironment.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] Rabbit Models of Ocular Diseases: New Relevance for Classical Approaches
    Zernii, Evgeni Y.
    Baksheeva, Viktoriia E.
    Iomdina, Elena N.
    Averina, Olga A.
    Permyakov, Sergei E.
    Philippov, Pavel P.
    Zamyatnin, Andrey A., Jr.
    Senin, Ivan I.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2016, 15 (03) : 267 - 291
  • [2] Responsive Microneedles for Diagnostic and Therapeutic Applications of Ocular Diseases
    Mi, Baoyue
    Mu, Jingqing
    Ding, Xiangyu
    Guo, Shutao
    Hua, Xia
    SMALL METHODS, 2025,
  • [3] Advances in Extracellular-Vesicles-Based Diagnostic and Therapeutic Approaches for Ocular Diseases
    Su, Yun
    Chen, Moxin
    Xu, Wei
    Gu, Ping
    Fan, Xianqun
    ACS NANO, 2024, 18 (34) : 22793 - 22828
  • [4] Modern approaches to the ocular delivery of cyclosporine A
    Agarwal, Priyanka
    Rupenthal, Ilva D.
    DRUG DISCOVERY TODAY, 2016, 21 (06) : 977 - 988
  • [5] Noninfectious Immune-Mediated Uveitis and Ocular Inflammation
    Pan, Jennifer
    Kapur, Manuj
    McCallum, Rex
    CURRENT ALLERGY AND ASTHMA REPORTS, 2014, 14 (01)
  • [6] Noninfectious Immune-Mediated Uveitis and Ocular Inflammation
    Jennifer Pan
    Manuj Kapur
    Rex McCallum
    Current Allergy and Asthma Reports, 2014, 14
  • [7] Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation
    Wang, Xudong
    Wang, Tianxi
    Lam, Enton
    Alvarez, David
    Sun, Ye
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [8] Editorial: Next Therapeutic Targets in Ocular Diseases
    Yanai, Ryoji
    Okunuki, Yoko
    Park, Dong Ho
    Zunaina, Embong
    FRONTIERS IN MEDICINE, 2022, 9
  • [9] Ocular Complications of Diabetes and Therapeutic Approaches
    Vieira-Potter, Victoria J.
    Karamichos, Dimitrios
    Lee, Darren J.
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [10] Immunotherapeutic approaches in ocular inflammatory diseases
    Kurup, SK
    Chan, CC
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2005, 53 (06) : 484 - 496